GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (OSTO:EGTX) » Definitions » Price-to-Tangible-Book

Egetis Therapeutics AB (OSTO:EGTX) Price-to-Tangible-Book : 38.94 (As of May. 29, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Egetis Therapeutics AB Price-to-Tangible-Book?

As of today (2025-05-29), Egetis Therapeutics AB's share price is kr3.115. Egetis Therapeutics AB's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was kr0.08. Hence, Egetis Therapeutics AB's Price to Tangible Book Ratio of today is 38.94.

The historical rank and industry rank for Egetis Therapeutics AB's Price-to-Tangible-Book or its related term are showing as below:

OSTO:EGTX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.56   Med: 5.02   Max: 63.84
Current: 38.94

During the past 13 years, Egetis Therapeutics AB's highest Price to Tangible Book Ratio was 63.84. The lowest was 1.56. And the median was 5.02.

OSTO:EGTX's Price-to-Tangible-Book is ranked worse than
96.99% of 1197 companies
in the Biotechnology industry
Industry Median: 2.75 vs OSTO:EGTX: 38.94

A closely related ratio is called PB Ratio. As of today, Egetis Therapeutics AB's share price is kr3.115. Egetis Therapeutics AB's Book Value per Sharefor the quarter that ended in Mar. 2025 was kr1.21. Hence, Egetis Therapeutics AB's P/B Ratio of today is 2.58.


Egetis Therapeutics AB Price-to-Tangible-Book Historical Data

The historical data trend for Egetis Therapeutics AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egetis Therapeutics AB Price-to-Tangible-Book Chart

Egetis Therapeutics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.65 9.57 15.88 11.97 29.66

Egetis Therapeutics AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.64 - - 29.66 49.81

Competitive Comparison of Egetis Therapeutics AB's Price-to-Tangible-Book

For the Biotechnology subindustry, Egetis Therapeutics AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Egetis Therapeutics AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Egetis Therapeutics AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Egetis Therapeutics AB's Price-to-Tangible-Book falls into.


;
;

Egetis Therapeutics AB Price-to-Tangible-Book Calculation

Egetis Therapeutics AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2025 )
=3.115/0.08
=38.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Egetis Therapeutics AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Egetis Therapeutics AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Egetis Therapeutics AB Business Description

Traded in Other Exchanges
Address
Grev Turegatan 11 C, Stockholm, SWE, 114 46
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines